While ARMS-PCR for NUDT15 and TPMT variants has been reported in other populations, this is the first study to integrate in silico variant prioritization with clinical validation on an Indian pediatric ALL cohort, establishing population-specific diagnostic utility. This evidence concerns the gene TPMT and acute lymphoblastic leukemia.